Ken Griffin’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$92.1M Buy
1,293,268
+917,266
+244% +$72.3M 0.01% 871
2025
Q4
$30.8M Sell
376,002
-1,663,347
-82% -$130M ﹤0.01% 1872
2025
Q3
$153M Sell
2,039,349
-7,260,580
-78% -$542M 0.02% 609
2025
Q2
$689M Buy
9,299,929
+2,383,389
+34% +$166M 0.12% 105
2025
Q1
$558M Buy
6,916,540
+6,428,164
+1,316% +$552M 0.11% 110
2024
Q4
$38.2M Sell
488,376
-3,058,206
-86% -$260M 0.01% 1519
2024
Q3
$333M Buy
3,546,582
+3,546,548
+10,431,024% +$298M 0.06% 216
2024
Q2
$2.65K Sell
34
-2,210,418
-100% -$180M ﹤0.01% 13663
2024
Q1
$201M Buy
2,210,452
+2,207,224
+68,377% +$184M 0.04% 367
2023
Q4
$250K Sell
3,228
-163,922
-98% -$11.5M ﹤0.01% 9522
2023
Q3
$11.4M Sell
167,150
-1,450,542
-90% -$106M ﹤0.01% 2526
2023
Q2
$131M Buy
1,617,692
+1,346,362
+496% +$107M 0.03% 475
2023
Q1
$22.3M Buy
271,330
+264,930
+4,140% +$18.9M ﹤0.01% 1815
2022
Q4
$374K Buy
+6,400
New +$369K ﹤0.01% 8856

Other funds holding GEHC

Ken Griffin's GEHC Position: Q1 2026 in Review

Ken Griffin increased its GE HealthCare (GEHC) stake by 244% in Q1 2026, buying an estimated $72.3M and bringing the position to 1,293,268 shares worth $92.1M. The position accounts for 0.01% of the portfolio, ranked #871.

Ken Griffin first reported a position in GEHC in Q4 2022 and has held it in 14 quarters since. The position peaked at $689M in Q2 2025. 1,269 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Ken Griffin held 1,293,268 shares of GE HealthCare worth $92.1M as of Q1 2026.
  • Ken Griffin bought 917,266 GE HealthCare shares in Q1 2026, an estimated $72.3M.
  • GE HealthCare made up 0.01% of Ken Griffin's portfolio in Q1 2026, its #871 holding.
  • Ken Griffin first reported a position in GE HealthCare in Q4 2022 and has held it in 14 quarters since.
  • Ken Griffin's GE HealthCare position peaked at $689M in Q2 2025.
  • 1,269 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.